Fluidigm Launches Higher-Throughput BioMark; Will Discontinue First-Gen System by Year End

The company said the new platform, the BioMark HD, will have twice the throughput as its predecessor, enabling faster time to result and allowing customers to more easily perform large-scale single-cell gene expression studies.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.